Use of A-549 Cells in a Clinical Virology Laboratory
Overview
Affiliations
A-549 cells were compared with other cell lines for virus recovery, except from specimens submitted specifically for detection of cytomegalovirus. Of 589 specimens submitted specifically for detection of herpes simplex virus (HSV), 163 (28%) were positive for HSV--159 (97.5%) in A-549 cells and 156 (96%) in primary rabbit kidney cells. HSV cytopathic effect was identified an average of 0.6 day earlier in A-549 cells. Virus was recovered from 194 (11%) of 1,790 specimens submitted for general virus isolation. Of 40 HSV isolates, 85% were positive in A-549 cells, 72.5% were positive in MRC-5/WI-38 cells, and 42.5% were positive in HEp-2 cells. With adenovirus, 96% of 45 isolates were detected in A-549 cells, 62% were detected in HEp-2 cells, 38% were detected in MRC-5/WI-38 cells, and 31% were detected in PMK cells. Of the 76 enterovirus-positive specimens, 71% were positive in PMK cells, 62% were positive in A-549 cells, and 62% were positive in MRC-5/WI-38 cells. None of 12 respiratory syncytial virus, 14 rhinovirus, or 7 influenza A virus isolates were detected in A-549 cells. Of the cell lines examined, A-549 cells performed optimally for recovery of HSV and adenovirus, they allowed good growth of many of the enterovirus isolates, but they did not allow recovery of any of the respiratory syncytial virus, rhinovirus, or influenza A virus isolates.
Aydamirov A, Harbiyeli I, Ozturk G, Yarkin F, Erdem E, Yagmur M Int Ophthalmol. 2022; 43(5):1701-1710.
PMID: 36346478 DOI: 10.1007/s10792-022-02567-0.
Liu H, Zhang M, Feng C, Cong S, Xu D, Sun H Front Cell Infect Microbiol. 2021; 11:700191.
PMID: 34490141 PMC: 8418080. DOI: 10.3389/fcimb.2021.700191.
Vaccine development for human mastadenovirus.
Chen S, Tian X J Thorac Dis. 2018; 10(Suppl 19):S2280-S2294.
PMID: 30116607 PMC: 6072920. DOI: 10.21037/jtd.2018.03.168.
Simple and cost-effective restriction endonuclease analysis of human adenoviruses.
Adhikary A, Hanaoka N, Fujimoto T Biomed Res Int. 2014; 2014:363790.
PMID: 24734232 PMC: 3966470. DOI: 10.1155/2014/363790.
Freymuth F, Vabret A, Cuvillon-Nimal D, Simon S, Dina J, Legrand L J Med Virol. 2006; 78(11):1498-504.
PMID: 16998894 PMC: 7159369. DOI: 10.1002/jmv.20725.